Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anthracyclines.

B K Sinha, P M Politi

    Cancer Chemotherapy and Biological Response Modifiers
    |January 1, 1990
    PubMed
    Summary
    This summary is machine-generated.

    Anthracycline drugs kill tumor cells through various mechanisms, including free radical formation and DNA damage. Resistance varies by cell type, with factors like P-170 and other proteins influencing drug accumulation and efficacy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Growth and flowering response of Lagurus (Lagurus ovatus L.) to Ascophyllum nodosum extract based biostimulant and gibberellic acid (GA<sub>3</sub>) application.

    BMC plant biology·2026
    Same author

    Nutritional composition, mineral content, antioxidant activity and quantitative estimation of water soluble vitamins and phenolics by RP-HPLC in some lesser used wild edible plants.

    Heliyon·2019
    Same author

    Characterization of grain nutritional quality in wheat.

    Indian journal of plant physiology·2014
    Same author

    Prevalence of psychiatric disorders in ahmedabad (an epidemiological study).

    Indian journal of psychiatry·2011
    Same author

    Relationship between lichen planus and hepatitis C virus.

    Indian journal of dermatology, venereology and leprology·2010
    Same author

    Experimental studies of transient, thermal depolarization in a Nd:glass laser rod.

    Applied optics·2010
    Same journal

    Native and genetically engineered anti-disialoganglioside monoclonal antibody treatment of melanoma.

    Cancer chemotherapy and biological response modifiers·2005
    Same journal

    Human tumor associated antigen mimicry by xenoantigens, anti-idiotypic antibodies and peptide mimics: implications for immunotherapy of malignant diseases.

    Cancer chemotherapy and biological response modifiers·2005
    Same journal

    DNA vaccines for melanoma.

    Cancer chemotherapy and biological response modifiers·2005
    Same journal

    Immunizing against partially defined antigen mixtures, gangliosides, or peptides to induce antibody, T cell, and clinical responses.

    Cancer chemotherapy and biological response modifiers·2005
    Same journal

    Chemotherapy, cytokines, and biochemotherapy for melanoma.

    Cancer chemotherapy and biological response modifiers·2005
    Same journal

    Current status of interferon-alpha in the treatment of melanoma.

    Cancer chemotherapy and biological response modifiers·2005
    See all related articles

    Area of Science:

    • Oncology
    • Pharmacology
    • Molecular Biology

    Background:

    • Anthracyclines are crucial chemotherapy agents, but their precise mechanisms of tumor cell killing and resistance remain incompletely understood.
    • Recent research has focused on free radical formation, topoisomerase II (topo II)-induced DNA breakage, and P-170-mediated drug accumulation as key factors.

    Purpose of the Study:

    • To elucidate the multifaceted mechanisms by which anthracyclines induce tumor cell death.
    • To investigate the molecular underpinnings of tumor cell resistance to anthracycline chemotherapy.
    • To review recent clinical findings regarding anthracycline efficacy and toxicity.

    Main Methods:

    • Analysis of tumor cell lines to assess the role of free radical species in anthracycline cytotoxicity.

    Related Experiment Videos

  • Evaluation of topoisomerase II activity and DNA cleavage in sensitive versus resistant cell lines.
  • Investigation of drug accumulation and the involvement of P-170 and other proteins in multidrug resistance.

    • Main Results:

    • Free radical formation contributes to anthracycline-induced cell killing, but this mechanism can be cell- or tissue-specific.
    • Topo II-dependent DNA cleavage is observed in most cell lines, with reduced DNA breaks in resistant cells, though topo II activity differences are modest.
    • Reduced drug accumulation is not the sole factor in multidrug resistance; P-170 and other proteins like an 85,000 Da protein may play roles.
    • While glutathione S-transferase (GST) is often overexpressed in resistant cells, its direct involvement in adriamycin resistance is uncertain.

    Conclusions:

    • The mechanisms of anthracycline action and resistance are complex and vary significantly among different tumor cell lines.
    • Clinical studies suggest protective roles for agents like ICRF-187 against cardiac toxicity and modest therapeutic index improvements with analogs like idarubicin and epirubicin.
    • Further research is needed to determine if increased anthracycline dosage or newer analogs significantly improve response rates, survival, or benefit patients refractory to existing treatments.